Lilly Industries

Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana, with a significant presence in the United Kingdom operating as Lilly Industries Limited. The company is renowned for its pioneering work in insulin and has recently transformed the landscape of metabolic health with its incretin-based therapies, Mounjaro and Zepbound. Lilly's diverse portfolio spans oncology, immunology, and neuroscience, featuring key products such as Verzenio, Taltz, and the recently approved Alzheimer's treatment, Kisunla. The organization maintains a robust R&D engine, complemented by strategic acquisitions in high-growth areas like radiopharmaceuticals and genetic medicines. With a global manufacturing footprint and a deep late-stage pipeline, Lilly continues to drive innovation to address some of the world's most challenging healthcare needs.